Rct. Aguiar et al., Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas, J CLIN END, 86(6), 2001, pp. 2890-2894
Pheochromocytomas are neural crest-derived tumors that occur mostly sporadi
cally, but may also be part of inherited syndromes. The molecular pathogene
sis of sporadic pheochromocytomas remains unknown. Recently, the susceptibi
lity gene for familial paraganglioma syndrome, a disorder embryologically r
elated to pheochromocytomas, was characterized and shown to encode the smal
l subunit of succinate dehydrogenase (SDHD), which is part of the mitochond
rial complex II. This complex regulates oxygen-sensing signals. Importantly
, hypoxic signals also appear to be related to the pathogenesis of pheothro
mocytomas associated with von Hippel-Lindau syndrome. We sequenced the enti
re coding region of the SDHD gene in a series of pheochromocytomas. Althoug
h we did not find mutations in the gene, we identified a new intronic singl
e nucleotide polymorphism in 15% of the samples (g.97739A-->G). We also con
firmed the existence of a sequence highly homologous to the SDHD complement
ary DNA in chromosome 1p34-36, a region commonly deleted in pheochromocytom
as. Full analysis of this sequence revealed a heterozygous single base subs
titution in 70% of our samples that was also present in the germline. This
sequence does not appear to be transcribed and is probably a processed pseu
dogene. Therefore, despite its chromosomal location, it is unlikely that th
is sequence is a target of loss of heterozygosity in pheochromocytomas. In
conclusion, mutations of the SDHD gene are not a common event in this serie
s of sporadic pheochromocytomas. The existence of SDHD pseudogenes should b
e considered when analyzing complementary DNA-based samples.